As a glucagon-like peptide-1 (GLP-1) receptor agonist, semaglutide powers Novo Nordisks blockbustersOzempic, Wegovy, and Rybelsusraking in billions ($14B for Ozempic in 2023!) to tackle type 2 diabetes and obesity
As I mentioned earlier, according to a 2016 study published in Currents in Neuropharmacology, it may also support the gut-brain barrier, which is critical for your gut and brain health ( 7 )
It provides GLP-1-adapted nutritional guidance using the Points system, app-based injection and meal tracking, virtual workshops, and a large online community
Diabetologia 29:4654 Knop FK, Vilsbll T, Hjberg PV et al (2007) Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state
By consuming this powerful antioxidant on a daily basis, you may strengthen your bodys defenses against dull skin and embrace a radiant complexion